Mad Honey Disease: A Rare Condition in an Unlikely Locale

<b>Background and Aims/Introduction:</b> Mad honey disease is caused by consuming honey containing grayanotoxanes-neurotoxins found in certain species of <i>Rhododendron</i> plants. Mad honey, derived from the nectar of these plants, can cause significant cardiovascular and neurological symptoms. While most cases are reported in regions where it is produced, extensive travel among diverse expatriate communities in various global regions is one of the factors that may contribute to cases occurring in nonendemic areas. Other factors leading to its increased demand include the global demand for its recreational and medicinal use, as well as its reputation as an aphrodisiac. Our case report on mad honey disease aims to raise awareness of this condition, highlight its clinical presentation and management, and emphasize the possibility of its occurrence outside endemic regions. <b>Case Presentation:</b> A 40-year-old Nepalese male living in Qatar presented with dizziness, hypotension, and severe bradycardia a few hours after consuming approximately 50 g of imported mad honey from Nepal. His admission ECG revealed sinus bradycardia without evidence of heart block. Initial stabilization was achieved with 0.5 mg of atropine and a norepinephrine infusion. The patient's symptoms resolved with supportive care while he was closely observed in the intensive care unit. He was discharged symptom free after 24 h. <b>Conclusion:</b> This case, to the best of our knowledge, represents the first reported incidence of mad honey disease in Qatar, emphasizing the importance of recognizing this rare condition in nonendemic areas. Proper history-taking, particularly with a focus on food and ingestion history, along with a high index of clinical suspicion, is crucial for timely diagnosis and management. While unintentional and accidental overdose and poisoning, as occurred in our case, may happen sporadically, the widespread use and import/export of mad honey necessitates stringent measures and precautions, similar to those adopted by various countries.

Authors

Institutions

Publication Details

Journal
Case Reports in Medicine
Published
2025-01-01
DOI
https://doi.org/10.1155/carm/2632633
Citations
1
Primary Topic
Bioactive Natural Diterpenoids Research
Type
article
Field-Weighted Citation Impact
0.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mad Honey Disease: A Rare Condition in an Unlikely Locale

Bassem Al Hariri, Sarfaraz Jamal, Emadaldin Elamir, S. Usman et al.
1 citations
Case Reports in Medicine
Bioactive Natural Diterpenoids Research
0.81
article

Mad Honey Disease: A Rare Condition in an Unlikely Locale

Bassem Al Hariri, Sarfaraz Jamal, Emadaldin Elamir, S. Usman, Eiman Rashid Musa, Harris Poolakundan, Maryam Almahri, Adnan Abdul Khaleq, Zidan Darwish, Anas Zayad
article en
1 citations

Abstract

<b>Background and Aims/Introduction:</b> Mad honey disease is caused by consuming honey containing grayanotoxanes-neurotoxins found in certain species of <i>Rhododendron</i> plants. Mad honey, derived from the nectar of these plants, can cause significant cardiovascular and neurological symptoms. While most cases are reported in regions where it is produced, extensive travel among diverse expatriate communities in various global regions is one of the factors that may contribute to cases occurring in nonendemic areas. Other factors leading to its increased demand include the global demand for its recreational and medicinal use, as well as its reputation as an aphrodisiac. Our case report on mad honey disease aims to raise awareness of this condition, highlight its clinical presentation and management, and emphasize the possibility of its occurrence outside endemic regions. <b>Case Presentation:</b> A 40-year-old Nepalese male living in Qatar presented with dizziness, hypotension, and severe bradycardia a few hours after consuming approximately 50 g of imported mad honey from Nepal. His admission ECG revealed sinus bradycardia without evidence of heart block. Initial stabilization was achieved with 0.5 mg of atropine and a norepinephrine infusion. The patient's symptoms resolved with supportive care while he was closely observed in the intensive care unit. He was discharged symptom free after 24 h. <b>Conclusion:</b> This case, to the best of our knowledge, represents the first reported incidence of mad honey disease in Qatar, emphasizing the importance of recognizing this rare condition in nonendemic areas. Proper history-taking, particularly with a focus on food and ingestion history, along with a high index of clinical suspicion, is crucial for timely diagnosis and management. While unintentional and accidental overdose and poisoning, as occurred in our case, may happen sporadically, the widespread use and import/export of mad honey necessitates stringent measures and precautions, similar to those adopted by various countries.

Case Reports in MedicineVol. 2025(1)
Hamad General Hospital (QA), Weill Cornell Medical College in Qatar (QA), Hamad Medical Corporation (QA), Qatar University (QA)
Openalex Percentile: Top 27%
Bioactive Natural Diterpenoids Research
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.